Tuesday, April 17, 2018 7:04:44 PM
They are now looking for 3X dilution for basically spinning the wheels of their current trials.
1) DCVAX-L Trial. Unblind date is unknown. We are all so blind now we are prepared to blindly vote "yes" to 3X dilution and massive board compensation with absolutely no idea when and if this trial will ever end. Meanwhile competitors are able to get statistical evidence after 10.5 months not 10.5 years. If this represents the Holy Grail of cancer cure then we the investors are the Monty Python crew looking for the Holy Grail while the rest of the world laughs at us.
2) DCVAX-D Trial. No progress at all. Even though this trial spread fear into BP's supposedly, NWBO in all it's infinite wisdom have decided it is so damn good it is not worth pursuing any more.
3) DCVAX-L Combo Trials. Continual cycle of delay after delay. No progress at all except another note from the company informing it's legion of salivating investors that they will have to wait another 6 months. The blind donkey is finding it very hard to sniff out this carrot anymore.
4) DCVAX-L Blinded Interim Paper by 67 scientists. Where is that "DAMN" paper, most likely being used as toilet paper in the yet to be completed manufacturing facility in Sawston owned by Advent which is owned by whom. Well who the hell knows except the person using the manuscript as toilet paper. Now that person has more knowledge than all us dumb blind investors hoping and praying for a golden carrot that at some point in the future be delivered by the esteemed and honorable CEO of NWBO.
Still waiting on news patiently and hoping that all of us longs on this board wont have to munch on those damn carrots for much longer because that s**t is getting old.
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM